Stuart Spencer
- Oncology top 1%
- Reproductive Medicine top 0.5%
- Molecular Biology top 10%
- Genetics top 5%
- Cancer Research top 10%
- Co-authors
- Anitra FieldingJonathan A. LedermannCharlie GourleyDarren HodgsonPhilipp HarterDaniela MateiMichael FriedländerTamar Safra
- Topics
- PARP inhibition in cancer therapy (17 papers)Ovarian cancer diagnosis and treatment (13 papers)BRCA gene mutations in cancer (12 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stuart Spencer
47 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 1.7k
- Reproductive Medicine 941
- Molecular Biology 902
- Genetics 620
- Cancer Research 238
Countries citing papers authored by Stuart Spencer
This map shows the geographic impact of Stuart Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Spencer more than expected).
Fields of papers citing papers by Stuart Spencer
This network shows the impact of papers produced by Stuart Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Spencer. The network helps show where Stuart Spencer may publish in the future.
Co-authorship network of co-authors of Stuart Spencer
This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Spencer. A scholar is included among the top collaborators of Stuart Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Spencer. Stuart Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 27 | |
| 3 | 17 | |
| 4 | 2 | |
| 5 | 167 | |
| 6 | 10 | |
| 7 | 3 | |
| 8 | Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer | 1 |
| 9 | 43 | |
| 10 | 17 | |
| 11 | 14 | |
| 12 | 13 | |
| 13 | Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialbreakdown → | 1060 |
| 14 | 24 | |
| 15 | 23 | |
| 16 | 129 | |
| 17 | 21 | |
| 18 | The Playwright's Guidebook | 1 |
| 19 | 3 | |
| 20 | 3 |
About Stuart Spencer
Stuart Spencer is a scholar working on Reproductive Medicine, Oncology and Otorhinolaryngology, having authored 48 papers that have together received 2.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (17 papers), Ovarian cancer diagnosis and treatment (13 papers) and BRCA gene mutations in cancer (12 papers). The work is most often cited by research in Reproductive Medicine (941 citations), Oncology (1.7k citations) and Genetics (620 citations). Stuart Spencer has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anitra Fielding, Jonathan A. Ledermann, Charlie Gourley, Darren Hodgson, Philipp Harter, Daniela Matei, Michael Friedländer, Tamar Safra, Ronnie Shapira‐Frommer and Werner Meier. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.